Fig 1: Expression of CMGs biomarkers are positively related to the efficacy of immunotherapy in TNBC. Representative multiplex immunofluorescence images demonstrating the protein expression of CD86 (blue), TNFRSF1B (red) and TNFRSF17 (purple) in samples from nonresponders (A) and responders (B); (C) Correlation analysis showed that TNFRSF1B, CD86 and TNFRSF17 were significantly associated with the immune response.